Effect of Tumor Treating Fields (TTFields, 200 kHz) Concomitant With Weekly Paclitaxel for the Treatment of Recurrent Ovarian Cancer (ENGOT-ov50 / GOG-3029 / INNOVATE-3)

NCT03940196 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

540

Enrollment

INDUSTRY

Sponsor class

Conditions

Ovarian Cancer

Interventions

DEVICE: NovoTTF-100L(O)
DRUG: Paclitaxel

Sponsor

NovoCure Ltd.